Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTirzepatide is legal in the UK. It holds a full MHRA marketing authorisation as a prescription-only medicine licensed for weight management and type 2 diabetes in adults. You cannot legally obtain it without a prescription following a clinical assessment — but with one, it is entirely lawful to use. If you have seen it described as banned, grey-market or unregulated, that description does not reflect the current position under UK law. The confusion usually comes from a separate, very real problem: counterfeit and illegally supplied pens being sold online. That is a different thing from the medicine itself, and the distinction matters.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A lot of people land on this question after seeing a social-media post, a news headline about seized pens, or a seller making claims that seem too easy. It is a reasonable thing to check, and the answer is reassuring. Tirzepatide is a fully licensed medicine in the UK. The MHRA authorised it, NICE appraised it, NHS England has begun rolling it out in primary care, and regulated pharmacies dispense it every day. None of that happens with an illegal substance.
What the law does do is place a condition on access. Under the Human Medicines Regulations 2012, tirzepatide is classified as a Prescription-Only Medicine. That means a qualified prescriber must assess whether it is clinically suitable for you before any supply can take place. Buying it without going through that step is not legal, not because of anything unusual about tirzepatide, but because that is exactly how UK law treats any medicine that needs clinical oversight.
The practical implication is straightforward. If you obtain tirzepatide through a registered UK pharmacy, following a consultation with a prescriber, you are on the right side of the law. If you purchase it from a source that skips that step, you are not, and the clinical risks are just as serious as the legal ones.
In October 2025, the MHRA raided a site in Northampton producing counterfeit tirzepatide pens. The enforcement operation was one of several: roughly 20 million doses of illegally traded weight-loss medicines, worth around £45 million, were seized during 2025. Those stories are important, but they are about supply, specifically, pens being manufactured and sold without a prescription or proper clinical oversight, often through social media.
The distinction matters. The counterfeiting problem is a reason to be careful about where you source tirzepatide, not evidence that the medicine is unsafe or prohibited. Counterfeit pens have been found to contain the wrong substances; fake pens seized in earlier operations contained insulin at dangerous concentrations. The MHRA's advice is to obtain any GLP-1 medicine through a pharmacy you can verify on the GPhC register, their public register is at pharmacyregulation.org/registers. You can read the MHRA's public guidance on this at the MHRA Drug Safety Updates page on GOV.UK.
Anything that offers tirzepatide without requiring a prescription and clinical review is a red flag, full stop. Discount codes, social-media DMs, and prices far below the market rate are all warning signs worth taking seriously.
The only lawful way to obtain tirzepatide in the UK is through a prescription issued by a qualified prescriber following an assessment of your suitability. That prescription can come via the NHS or through a regulated private pharmacy, both are legal routes, and both require clinical oversight.
On the NHS, access is phased. NICE's appraisal of tirzepatide (TA1026) set eligibility criteria that the NHS is rolling out in cohorts, starting with adults who have a higher BMI and multiple weight-related conditions. If you do not meet those criteria yet, or prefer not to wait, a regulated private clinic is a lawful alternative, provided the pharmacy is GPhC-registered and a real prescriber reviews your case.
For a fuller picture of what tirzepatide is, how it works and what the licensed dose schedule looks like, the tirzepatide overview page covers all of that in detail. If you are wondering specifically whether the brand name Mounjaro and tirzepatide are the same thing, the answer is yes, tirzepatide is simply the active ingredient; Mounjaro is the UK brand name.
There is also a related question worth separating out: selling tirzepatide without the proper authorisations carries its own legal consequences under UK law, that is covered separately on the page about whether it is illegal to sell tirzepatide in the UK.
If you are considering tirzepatide through a private pharmacy, knowing what the legitimate process looks like helps you judge any service you come across. A regulated UK provider will ask you to complete a clinical consultation, verify your identity with photo ID, check your weight, notify your GP in line with GPhC guidance, and have a GPhC-registered Independent Prescriber review your answers before any medicine is dispatched. The pharmacy itself will be listed on the GPhC register with a verifiable premises number.
Cost is a real consideration. Private tirzepatide prices have changed significantly since Eli Lilly revised UK list pricing in September 2025, the Mounjaro prices page explains the current market context honestly, including what a legitimate private price typically includes beyond the pen itself.
At nume, a GPhC-registered Independent Prescriber reads every consultation personally (not software) on the same day it is submitted. Our GPhC premises registration number is 9012878, verifiable at pharmacyregulation.org. If you would like to check your eligibility and speak to our clinical team, you can start a free consultation here.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.